Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,025 | 19,246 | 24,534 | 22,250 | 24,234 |
| Marketable Securities | 126 | 135 | 219 | 383 | N/A |
| Receivables | N/A | N/A | N/A | N/A | 50 |
| TOTAL | $17,891 | $20,476 | $26,067 | $23,193 | $25,240 |
| Non-Current Assets | |||||
| PPE Net | 8 | 9 | 10 | 11 | 12 |
| TOTAL | $8 | $9 | $10 | $11 | $12 |
| Total Assets | $17,899 | $20,485 | $26,077 | $23,204 | $25,252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 215 | 538 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,886 | 1,579 | 1,584 | 1,434 | 1,496 |
| Accrued Expenses | 1,418 | 1,419 | 1,733 | 1,204 | 1,203 |
| TOTAL | $3,304 | $3,213 | $3,855 | $2,638 | $2,699 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,304 | $3,213 | $3,855 | $2,638 | $2,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,580 | 19,364 | 18,990 | 17,300 | 16,897 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -100,890 | -95,963 | -89,368 | -83,055 | -78,825 |
| TOTAL | $14,595 | $17,272 | $22,222 | $20,566 | $22,553 |
| Total Liabilities And Equity | $17,899 | $20,485 | $26,077 | $23,204 | $25,252 |